HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li-Chun Cheng Selected Research

ADP-Ribosylation Factors (ADP-Ribosylation Factor)

1/2017ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li-Chun Cheng Research Topics

Disease

8Neoplasms (Cancer)
02/2024 - 01/2017
2Melanoma (Melanoma, Malignant)
02/2024 - 01/2024
1Colorectal Neoplasms (Colorectal Cancer)
10/2023
1Brain Ischemia (Cerebral Ischemia)
01/2022
1Infarction (Infarctions)
01/2022
1Reperfusion Injury
01/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022
1Mouth Neoplasms (Oral Cancer)
12/2020
1Bites and Stings (Sting)
12/2020
1Inflammation (Inflammations)
12/2020
1Neoplasm Metastasis (Metastasis)
11/2019
1Cadaver (Cadavers)
11/2003

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
02/2024 - 11/2018
2Immune Checkpoint InhibitorsIBA
02/2024 - 01/2024
1NAD (NADH)IBA
02/2024
1AntigensIBA
02/2024
1Fructose-Bisphosphate Aldolase (Aldolase)IBA
10/2023
1Caspase 3 (Caspase-3)IBA
01/2022
1NMDA receptor A1IBA
01/2022
1SolutionsIBA
01/2022
1Valproic Acid (Depakote)FDA LinkGeneric
01/2022
1Neuroprotective AgentsIBA
01/2022
1tanshinoneIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2020
1Mitochondrial DNA (mtDNA)IBA
12/2020
1Glucose (Dextrose)FDA LinkGeneric
11/2018
1Drug CarriersIBA
01/2017
1MicellesIBA
01/2017
1Adenosine Diphosphate (ADP)IBA
01/2017
1ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA
01/2017
1GTP Phosphohydrolases (GTPases)IBA
11/2003
1Proto-Oncogene Proteins c-crkIBA
11/2003

Therapy/Procedure

4Therapeutics
01/2024 - 11/2019
3Immunotherapy
02/2024 - 12/2020
1Aftercare (After-Treatment)
01/2024